An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer
Clinical trial NCT04745988 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04745988
- Sponsor
- National Cancer Center Hospital East
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-11
- Primary completion
- 2026-08-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.